Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Chappell Dale, Directeur Scientifique. Officer active across 1 company, notably Humanigen, INC. In total, 13 reports have been recorded. Split: 2 buys · 11 sells. Total volume traded: €1.6m. Activity tracked since 2 June 2021. The latest transaction was filed on 18 October 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Chappell Dale
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12,028 shares@ US$19.011511.5% of flowCommon Stock, $0.001 par valueSEC:0001013594-21-000503:0
13 of 13 declarations
About Chappell Dale
Chappell Dale is Chief Scientific Officer and Director Scientifique at Humanigen, INC, listed on XNAS. He has filed 13 disclosures, and across the sampled recent filings from 2021-06-04 to 2023-10-20, purchases total EUR 304924 and sales total EUR 1329700, with a dominant transaction nature of sale.